https://sputniknews.in/20260730/russia-set-to-begin-melanoma-vaccine-treatment-for-first-10-patients-11823187.html
Russia Set to Begin Melanoma Vaccine Treatment for First 10 Patients
Russia Set to Begin Melanoma Vaccine Treatment for First 10 Patients
Sputnik India
Vaccines against skin cancer are being developed for ten patients and will be ready within one and a half to three months, Alexander Gintsburg, Academician of... 30.07.2026, Sputnik India
2026-07-30T15:02+0530
2026-07-30T15:02+0530
2026-07-30T15:02+0530
world news
health
science & tech
russia
https://cdn1.img.sputniknews.in/img/07e9/01/1b/8708493_0:159:2802:1735_1920x0_80_0_0_71c5aaf3a55d3b2210cff6f3b5ffc2e8.jpg
"We are currently developing the drugs [personalized vaccines against skin cancer] for ten patients, which will be completed within one and a half to three months," Gintsburg said.Earlier, the first patient received a personalized vaccine for the treatment of melanoma.The vaccine, designated "NEOONCOVAC," was developed jointly by the Gamaleya Center and the Blokhin National Medical Research Center of Oncology, and is manufactured by the National Medical Research Center of Radiology.In November 2025, the Russian Ministry of Health also issued a permit for the clinical use of the personalized therapeutic cancer vaccine "Oncopept," developed by the Federal Medical-Biological Agency (FMBA), for the treatment of colorectal cancer.
https://sputniknews.in/20260730/russian-army-launch-massive-strikes-on-ukrainian-airfields-and-defence-plants-mod-11821261.html
russia
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
health, science & tech, russia
health, science & tech, russia
Russia Set to Begin Melanoma Vaccine Treatment for First 10 Patients
Vaccines against skin cancer are being developed for ten patients and will be ready within one and a half to three months, Alexander Gintsburg, Academician of the Russian Academy of Sciences and Scientific Director of the Gamaleya National Research Center for Epidemiology and Microbiology, told Sputnik.
"We are currently developing the drugs [personalized vaccines against skin cancer] for ten patients, which will be completed within one and a half to three months," Gintsburg said.
Earlier, the first patient received a personalized vaccine for the treatment of melanoma.
The vaccine, designated "NEOONCOVAC," was developed jointly by the Gamaleya Center and the Blokhin National Medical Research Center of Oncology, and is manufactured by the National Medical Research Center of Radiology.
In November 2025, the Russian Ministry of Health also issued a permit for the clinical use of the personalized therapeutic cancer vaccine "Oncopept," developed by the Federal Medical-Biological Agency (FMBA), for the treatment of colorectal cancer.
